| 000 | 01803 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513221827.0 | ||
| 264 | 0 | _c20010208 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0094-6176 | ||
| 024 | 7 |
_a10.1055/s-2000-8097 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWillems, H P | |
| 245 | 0 | 0 |
_aHomocysteine and venous thrombosis: outline of a vitamin intervention trial. _h[electronic resource] |
| 260 |
_bSeminars in thrombosis and hemostasis _c2000 |
||
| 300 |
_a297-304 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFolic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHomocysteine _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperhomocysteinemia _xcomplications |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNetherlands _xepidemiology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPulmonary Embolism _xblood |
| 650 | 0 | 4 |
_aPyridoxine _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSecondary Prevention |
| 650 | 0 | 4 |
_aThrombophilia _xblood |
| 650 | 0 | 4 |
_aThrombophlebitis _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUltrasonography |
| 650 | 0 | 4 |
_aVenous Thrombosis _xetiology |
| 650 | 0 | 4 |
_aVitamin B 12 _xadministration & dosage |
| 700 | 1 | _aden Heijer, M | |
| 700 | 1 | _aBos, G M | |
| 773 | 0 |
_tSeminars in thrombosis and hemostasis _gvol. 26 _gno. 3 _gp. 297-304 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2000-8097 _zAvailable from publisher's website |
| 999 |
_c10957663 _d10957663 |
||